Audio Journal of OncologyIs breast cancer screening oversold?
ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of
29/03/2013
Audio Journal of OncologyLow risk prostate cancer: scope and benefits from reducing overtreatment
ORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital, the Dana-Farber Ca
24/03/2013
Audio Journal of OncologyEnzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too
ORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM stu
24/03/2013
Audio Journal of OncologyLow risk localized prostate cancer: no harm from waiting!
ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Sympo
24/03/2013
Audio Journal of OncologyAndrogen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancer
ORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months — but have fewer side effec
24/03/2013
Audio Journal of OncologyLow risk localized prostate cancer: no harm from waiting!
ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Sympo
16/03/2013
Audio Journal of OncologyLow risk prostate cancer: less treatment means lower cost, and better patient outcomes
ORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital,
16/03/2013
Audio Journal of OncologyAndrogen Blockade: 18 As Good As 36 Months In Radiotherapy-Treated Prostate Cancer
ORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months
16/03/2013
Audio Journal of OncologyMDFM News: Overview of the 2nd World Summit on Gut Microbiota (section of the European Society of Neurogastroenterology and Motility)
Headlines: – Pr James Versalovic : Microbial ecology of the gastrointestinal tract – Pr Francisco Guarner : Gut microbiota and the immune system education – Pr Fernando Aspiroz : Gut
05/03/2013- Audio Journal of Oncology
MDFM News: CARDIOVASCULAR DISEASE: Mediterranean diet more effective at reducing CAD than low-fat diet in high risk patients
Other headlines: – CABG should remain the standard of care for patients with multivessel coronary artery disease – Determinants of weight gain from intensive glucose-lowering treatment 
05/03/2013 - Audio Journal of Oncology
MDFM News: PROSTATE CANCER at ASCO GU: 18 months of androgen blockade as safe and effective as 36 months in node-negative high-risk patients
Other headlines: – Raised incidence of HPV-associated cancers in the past 35 years in the United States. – Two new anticoagulants for the extended treatment of patients with unprovoked ven
27/02/2013 - Audio Journal of Oncology
MDFM News: ACUTE ISCHEMIC STROKE: 3 randomized trials report no benefit of endovascular treatment over current standard of care
Other headlines: – Deep Brain Stimulation proved effective on motor skills and quality of life in patients at early stages of Parkinson’s disease. – Folic acid supplementation during
17/02/2013